Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: A preliminary report
Authors:
- Ildiko SarosiISIldiko Sarosi
- Girish N. VyasGVGirish N. Vyas
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 97 (5) , 1281-1287
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Relation of the hepatitis B virus carrier state to hepatocellular carcinomaHepatology, 1987
- THE MOLECULAR BIOLOGY OF THE HEPATITIS B VIRUSESAnnual Review of Biochemistry, 1987
- Aflatoxin exposure, hepatitis b virus infection and liver cancer in swazilandInternational Journal of Cancer, 1987
- Hepatitis B virus (HBV) and hepatocellular carcinomaJournal of Hepatology, 1987
- Monitoring of individual human exposure to aflatoxins (AF) and N‐nitrosamines (NNO) by immunoassaysJournal of Cellular Biochemistry, 1986
- Hepatocellular carcinoma and dietary aflatoxin in Mozambique and TranskeiBritish Journal of Cancer, 1985
- Hepatitis B Virus Status of Southern African Blacks With Hepatocellular Carcinoma: Comparison Between Rural and Urban PatientsHepatology, 1983
- Metabolic Activation of Aflatoxin B1: Patterns of DNA Adduct Formation, Removal, and Excretion in Relation to CarcinogenesisDrug Metabolism Reviews, 1982
- Primary liver cancer and its relationship to chronic infection with the hepatitis B virusSpringer Seminars in Immunopathology, 1981
- Detection of Hepatitis B Virus-specific DNA in the Genomes of Human Hepatocellular Carcinoma and Liver Cirrhosis TissuesJournal of General Virology, 1981